from China/India
chip fabs
mineral reserves
unprocessed
Four Critical Dependencies
Where Canada Is Exposed
80% of Active Ingredients From Two Countries
Approximately 80% of active pharmaceutical ingredients (APIs) used in Canadian medicines originate from China and India. During COVID-19, both countries restricted pharmaceutical exports. Canada had no domestic API manufacturing capacity to fall back on. The pandemic exposed that Canada's healthcare system depends on uninterrupted supply from countries that can restrict exports at will. The healthcare privatization pipeline is compounded by pharmaceutical supply dependence — even when patients can access care, the medicines may not be available if supply chains are disrupted.
Zero Domestic Fabrication
Canada has no advanced semiconductor fabrication facilities. Every chip in Canadian military equipment, telecommunications infrastructure, medical devices, and consumer electronics is imported. The global chip shortage (2020–2023) demonstrated the economic impact: auto manufacturing halted, electronics prices rose, and delivery timelines extended. Canada's Critical Minerals Strategy identifies semiconductor materials but does not address fabrication. In a conflict scenario, Canada's military — already degraded by leadership turnover — would depend entirely on foreign chip supply for weapons systems and communications.
Extract Raw, Import Finished — The Colonial Pattern
Canada holds the world's third-largest reserves of critical minerals including lithium, cobalt, nickel, graphite, and rare earth elements — essential for batteries, electronics, and clean energy. Yet Canada exports these minerals in raw or minimally processed form and imports finished batteries, electronics, and components at vastly higher prices. The $15B+ in EV battery subsidies was designed to address this — paying foreign multinationals to process Canadian minerals in Canada rather than developing domestic processing capacity. The pattern echoes colonial resource extraction: extract raw materials, ship them abroad, buy back finished goods at a premium.
COVID Exposed Everything
When COVID-19 hit, Canada could not produce adequate PPE, ventilators, or test kits domestically. The National Emergency Strategic Stockpile was depleted and expired. Emergency procurement from China and other countries produced quality concerns and delivery delays. The AG documented significant procurement failures during the pandemic response. Domestic medical manufacturing capacity has been marginally expanded since but remains far below the level needed for a major health emergency. The lesson of COVID was clear: supply chain dependence on foreign sources for essential medical supplies is a strategic vulnerability. The lesson has not been adequately addressed.
Sovereignty Requires Self-Sufficiency
A country that cannot manufacture its own medicines, fabricate its own chips, process its own minerals, or produce its own medical supplies is not sovereign.
The tariff crisis shows what happens when one supplier changes terms. The next pandemic will show what happens when multiple suppliers do. Supply chain dependence is the physical infrastructure of captured sovereignty.